Frontiers in Physiology · 2013 · 43 citations · 53 references
MedicineCardiologyPharmacologyClinical PharmacologyMolecular PharmacologyPharmacodynamicsBlood Pressure RegulationCardiovascular Molecular PhysiologyOxidative StressOxidative Stress MechanismsReactive Oxygen SpeciesReactive Oxygen Species BiologyBaroreflex CircuitsBaroreflex ControlBaroreflex PhysiologyMultifactorial EtiologyReactive Oxygen Species GenerationRenin-angiotensin-aldosterone SignalingRenin-angiotensin-aldosterone System ActivationRenin-angiotensin-aldosterone System Dysregulation
Hypertension is a multifactorial disorder, which has been associated with the reduction in baroreflex sensitivity (BRS) and autonomic dysfunction. Several studies have revealed that increased reactive oxygen species (ROS) generated by nicotinamide adenine dinucleotide phosphate [NAD(P)H] oxidase, following activation of type 1 receptor (AT1R) by Angiotensin-(Ang) II, the main peptide of the Renin-Angiotensin-Aldosterone System (RAAS), is the central mechanism involved in Ang-II-derived hypertension. In the present review, we will discuss the role of Ang II and oxidative stress in hypertension, the relationship between the BRS and the genesis of hypertension and how the oxidative stress triggers baroreflex dysfunction in several models of hypertension. Finally, we will describe some novel therapeutic drugs for improving the BRS during hypertension.
53
Sanjay Rajagopalan, Stephan Kurz, Thomas Münzel et al. · Journal of Clinical Investigation · 1996 · 2.4K citations · Full text